- 专利标题： ANTIBODIES THAT BIND CD277 AND USES THEREOF
-
申请号： PCT/US2019/046060申请日： 2019-08-09
-
公开(公告)号： WO2020033925A2公开(公告)日： 2020-02-13
- 发明人: SCHMIDT, Michael, March , LAJOIE, Jason, M. , LARSON, Eric , EVDOKIMOV, Artem
- 申请人： COMPASS THERAPEUTICS LLC
- 申请人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 代理机构： MANDRAGOURAS, Amy, E. et al.
- 优先权： US62/716,636 20180809
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61P35/00
摘要：
The present disclosure relates to, inter alia , methods for treating, or ameliorating one or more symptoms of, cancer, with compounds ( e.g. , antibodies, or antigen-binding fragments thereof) that bind to CD277.
公开/授权文献
- WO2020033925A9 ANTIBODIES THAT BIND CD277 AND USES THEREOF 公开/授权日：2020-02-13
